$AVD
AMERICAN VANGUARD CORP

2013 Q2 Form 10-Q Financial Statement

#000119312513319570 Filed on August 06, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $86.76M $84.84M
YoY Change 2.27% 5.96%
Cost Of Revenue $44.70M $46.49M
YoY Change -3.86% -3.94%
Gross Profit $42.07M $38.35M
YoY Change 9.7% 21.04%
Gross Profit Margin 48.48% 45.2%
Selling, General & Admin $24.10M $19.10M
YoY Change 26.18% 16.46%
% of Gross Profit 57.29% 49.81%
Research & Development $5.100M $5.000M
YoY Change 2.0% 8.7%
% of Gross Profit 12.12% 13.04%
Depreciation & Amortization $3.760M $3.580M
YoY Change 5.03% 2.87%
% of Gross Profit 8.94% 9.34%
Operating Expenses $29.17M $24.10M
YoY Change 21.01% 14.78%
Operating Profit $12.90M $14.24M
YoY Change -9.44% 33.34%
Interest Expense $701.0K $721.0K
YoY Change -2.77% -172.1%
% of Operating Profit 5.44% 5.06%
Other Income/Expense, Net
YoY Change
Pretax Income $12.23M $13.63M
YoY Change -10.31% 40.55%
Income Tax $3.961M $4.889M
% Of Pretax Income 32.4% 35.86%
Net Earnings $8.386M $8.744M
YoY Change -4.09% 45.56%
Net Earnings / Revenue 9.67% 10.31%
Basic Earnings Per Share $0.29 $0.31
Diluted Earnings Per Share $0.29 $0.30
COMMON SHARES
Basic Shares Outstanding 28.30M shares 27.86M shares
Diluted Shares Outstanding 28.89M shares 28.74M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.40M $48.00M
YoY Change -32.5% 380.0%
Cash & Equivalents $32.41M $48.05M
Short-Term Investments
Other Short-Term Assets $18.30M $4.400M
YoY Change 315.91% 33.33%
Inventory $127.2M $79.90M
Prepaid Expenses
Receivables $67.38M $72.80M
Other Receivables $1.500M $900.0K
Total Short-Term Assets $246.8M $206.1M
YoY Change 19.74% 21.95%
LONG-TERM ASSETS
Property, Plant & Equipment $49.83M $48.40M
YoY Change 2.95% 23.47%
Goodwill
YoY Change
Intangibles $110.2M
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.37M $4.100M
YoY Change 640.78% -16.33%
Total Long-Term Assets $190.4M $165.5M
YoY Change 15.07% 1.41%
TOTAL ASSETS
Total Short-Term Assets $246.8M $206.1M
Total Long-Term Assets $190.4M $165.5M
Total Assets $437.2M $371.6M
YoY Change 17.66% 11.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $23.95M $23.80M
YoY Change 0.64% -0.83%
Accrued Expenses $88.51M $63.90M
YoY Change 38.51% 60.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $70.00K $15.10M
YoY Change -99.54% 2.03%
Total Short-Term Liabilities $123.1M $104.1M
YoY Change 18.28% 28.52%
LONG-TERM LIABILITIES
Long-Term Debt $40.91M $41.00M
YoY Change -0.22% -27.05%
Other Long-Term Liabilities $4.300M $5.600M
YoY Change -23.21% -17.65%
Total Long-Term Liabilities $40.91M $46.60M
YoY Change -12.21% -26.03%
TOTAL LIABILITIES
Total Short-Term Liabilities $123.1M $104.1M
Total Long-Term Liabilities $40.91M $46.60M
Total Liabilities $187.5M $165.8M
YoY Change 13.08% 7.31%
SHAREHOLDERS EQUITY
Retained Earnings $196.2M
YoY Change
Common Stock $3.099M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $4.804M
YoY Change
Treasury Stock Shares 2.311M shares
Shareholders Equity $249.6M $205.8M
YoY Change
Total Liabilities & Shareholders Equity $437.2M $371.6M
YoY Change 17.66% 11.86%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $8.386M $8.744M
YoY Change -4.09% 45.56%
Depreciation, Depletion And Amortization $3.760M $3.580M
YoY Change 5.03% 2.87%
Cash From Operating Activities $38.19M $44.27M
YoY Change -13.73% 245.59%
INVESTING ACTIVITIES
Capital Expenditures -$3.960M -$7.340M
YoY Change -46.05% 420.57%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$3.970M -$7.340M
YoY Change -45.91% 420.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.38M -3.180M
YoY Change 257.86% 12.37%
NET CHANGE
Cash From Operating Activities 38.19M 44.27M
Cash From Investing Activities -3.970M -7.340M
Cash From Financing Activities -11.38M -3.180M
Net Change In Cash 22.84M 33.75M
YoY Change -32.33% 293.82%
FREE CASH FLOW
Cash From Operating Activities $38.19M $44.27M
Capital Expenditures -$3.960M -$7.340M
Free Cash Flow $42.15M $51.61M
YoY Change -18.33% 262.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2013Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.07
CY2013Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28664462 shares
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48048000
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
383701 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.71
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
692012 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.39
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.96
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1177000
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
242036000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30972048 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
383701 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.71
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
678679 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
24.39
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.07
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
2310634 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q2 us-gaap Number Of Interest Rate Derivatives Held
NumberOfInterestRateDerivativesHeld
1 Contract
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2013Q2 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
8793000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
70000
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
123126000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1479000
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
249746000
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
40911000
CY2013Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
74691000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
56632000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
23953000
CY2013Q2 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
254407000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
249603000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
196155000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
278000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88508000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
557000
CY2013Q2 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
4291000
CY2013Q2 us-gaap Minority Interest
MinorityInterest
143000
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
40981000
CY2013Q2 us-gaap Liabilities
Liabilities
187491000
CY2013Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1524000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
3099000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
437237000
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
19163000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30372000
CY2013Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
148000
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
110247000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67376000
CY2013Q2 us-gaap Inventory Net
InventoryNet
127150000
CY2013Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4877000
CY2013Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
124519000
CY2013Q2 us-gaap Cash
Cash
32414000
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
4804000
CY2013Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
115472000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49828000
CY2013Q2 us-gaap Assets
Assets
437237000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32414000
CY2013Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
11678000
CY2013Q2 us-gaap Other Receivables
OtherReceivables
1414000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13411000
CY2013Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
68938000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
246790000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35085000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30766730 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
245817 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.70
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
705345 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
20.23
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.95
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2310634 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2012Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
8671000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
16247000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
113670000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1762000
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
225436000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
36196000
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70458000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
54323000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
32838000
CY2012Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
229881000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
225077000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
174243000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20427000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32335000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
623000
CY2012Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
5425000
CY2012Q4 us-gaap Minority Interest
MinorityInterest
359000
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
52443000
CY2012Q4 us-gaap Liabilities
Liabilities
174454000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1839000
CY2012Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1313000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
3077000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
399890000
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
19163000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18351000
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
113521000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
76073000
CY2012Q4 us-gaap Inventory Net
InventoryNet
87951000
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4877000
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
116159000
CY2012Q4 us-gaap Cash
Cash
38476000
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
4804000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
74900000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
45701000
CY2012Q4 us-gaap Assets
Assets
399890000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38476000
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
13051000
CY2012Q4 us-gaap Other Receivables
OtherReceivables
1230000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13710000
CY2012Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
77303000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
222317000
dei Trading Symbol
TradingSymbol
AVD
dei Entity Registrant Name
EntityRegistrantName
AMERICAN VANGUARD CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0000005981
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-04-19
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28884000 shares
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-04-05
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7461000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
40750000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
20045000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12941000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-26000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20149000
us-gaap Interest Expense
InterestExpense
1248000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8532000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
527000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28280000 shares
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
8360000
us-gaap Sales Revenue Net
SalesRevenueNet
208298000
us-gaap Payments Of Dividends
PaymentsOfDividends
1976000
us-gaap Profit Loss
ProfitLoss
25085000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
192689000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
46000000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
57000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
352000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
38026000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-69000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9837000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1238000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25584000
us-gaap Gross Profit
GrossProfit
95847000
us-gaap Operating Income Loss
OperatingIncomeLoss
39049000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-8513000
us-gaap Net Income Loss
NetIncomeLoss
25301000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39199000
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
-616000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
225000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14034000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6036000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1747000
us-gaap Operating Expenses
OperatingExpenses
56798000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
86000
us-gaap Cost Of Revenue
CostOfRevenue
112451000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
54529000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
57000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1802000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
-1404000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6154000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12047000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-216000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
15609000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27740000 shares
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
13061000
us-gaap Sales Revenue Net
SalesRevenueNet
172092000
us-gaap Payments Of Dividends
PaymentsOfDividends
1380000
us-gaap Profit Loss
ProfitLoss
17478000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.63
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2012-04-16
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28544000 shares
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2012-04-01
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36668000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
155181000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4000000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
160000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
46000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27336000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
122000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2555000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17646000
us-gaap Gross Profit
GrossProfit
75724000
us-gaap Operating Income Loss
OperatingIncomeLoss
28644000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3862000
us-gaap Net Income Loss
NetIncomeLoss
17478000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8854000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
148000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10762000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
12845000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1031000
us-gaap Operating Expenses
OperatingExpenses
47080000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
396000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9858000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
118000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7370000
us-gaap Interest Expense
InterestExpense
1456000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
668000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1285000
us-gaap Cost Of Revenue
CostOfRevenue
96368000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
30883000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7046000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
160000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1574000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6827000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13061000
us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
393000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
16911000
CY2013Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2013-07-19
CY2013Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2013-07-05
CY2012Q2 avd Cash Dividend Paid
CashDividendPaid
1380000
CY2013Q2 avd Cash Dividend Paid
CashDividendPaid
1976000
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.50
CY2013Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
22.17
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6666 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
6667 shares
CY2013Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
31.27
CY2013Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.5
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
8000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
145884 shares
CY2013Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
378000
CY2013Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
57000
CY2013Q1 us-gaap Profit Loss
ProfitLoss
16819000
CY2013Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
178000
CY2013Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
407000
CY2013Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
49000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
585000
CY2013Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
688000
CY2013Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1976000
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28295000 shares
CY2013Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.5
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
8230 shares
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
86761000
CY2013Q2 us-gaap Profit Loss
ProfitLoss
8266000
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28737000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27858000 shares
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
84837000
CY2012Q2 us-gaap Profit Loss
ProfitLoss
8744000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
75292000
CY2012Q2 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
24000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13633000
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-420000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8348000
CY2012Q2 us-gaap Gross Profit
GrossProfit
38346000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14242000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
8744000
CY2012Q2 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
112000
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
24104000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4889000
CY2012Q2 us-gaap Interest Expense
InterestExpense
721000
CY2012Q2 us-gaap Cost Of Revenue
CostOfRevenue
46491000
CY2012Q2 avd Sales Of Non Crop Products
SalesOfNonCropProducts
9545000
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2013Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28886000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
8230 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
30.37
CY2013Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
13333 shares
CY2013Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.37
CY2013Q2 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
174000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
12227000
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-476000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
77145000
CY2013Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
101000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8084000
CY2013Q2 us-gaap Gross Profit
GrossProfit
42066000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
12897000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
8386000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-302000
CY2013Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1058000
CY2013Q2 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
31000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
29169000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3961000
CY2013Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1413000
CY2013Q2 us-gaap Interest Expense
InterestExpense
701000
CY2013Q2 us-gaap Cost Of Revenue
CostOfRevenue
44695000
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-120000
CY2013Q2 avd Sales Of Non Crop Products
SalesOfNonCropProducts
9616000

Files In Submission

Name View Source Status
0001193125-13-319570-index-headers.html Edgar Link pending
0001193125-13-319570-index.html Edgar Link pending
0001193125-13-319570.txt Edgar Link pending
0001193125-13-319570-xbrl.zip Edgar Link pending
avd-20130630.xml Edgar Link completed
avd-20130630.xsd Edgar Link pending
avd-20130630_cal.xml Edgar Link unprocessable
avd-20130630_def.xml Edgar Link unprocessable
avd-20130630_lab.xml Edgar Link unprocessable
avd-20130630_pre.xml Edgar Link unprocessable
d554703d10q.htm Edgar Link pending
d554703dex311.htm Edgar Link pending
d554703dex312.htm Edgar Link pending
d554703dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending